Literature DB >> 22028558

Application of sentinel lymph node biopsy in cutaneous basosquamous carcinoma.

Irena Jankovic1, Predrag Kovacevic, Milan Visnjic, Dimitrije Jankovic, Ivana Binic, Aleksandar Jankovic, Ivan Ilic.   

Abstract

Basosquamous carcinoma of the skin is a relatively rare cutaneous neoplasm that has significant metastatic potential and a metastatic rate greater than that of basal cell and squamous cell carcinoma. We describe the use of lymphatic mapping and sentinel lymph node biopsy in a 63-year-old man after identification of basosquamous carcinoma. Sentinel lymph node biopsy, which is a standard tool to detect regional lymphatic metastasis in cutaneous melanoma, has been rarely employed to detect lymphatic metastasis of basosquamous carcinoma. The approach was successful in detecting a regional lymphatic metastasis of two nodal basins with minor morbidity. Sentinel lymph node biopsy may be useful for certain high-risk lesions of basosquamous carcinoma.

Entities:  

Keywords:  Basosquamous carcinoma; Metastasis; Sentinel lymph node biopsy

Year:  2011        PMID: 22028558      PMCID: PMC3199408          DOI: 10.5021/ad.2011.23.S1.S123

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  8 in total

Review 1.  Cutaneous squamous-cell carcinoma.

Authors:  M Alam; D Ratner
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

Review 2.  Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature.

Authors:  David Costantino; Lori Lowe; David L Brown
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006       Impact factor: 2.740

Review 3.  Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature.

Authors:  Amy Simon Ross; Chrysalyne Delling Schmults
Journal:  Dermatol Surg       Date:  2006-11       Impact factor: 3.398

4.  The feasibility of sentinel lymph node biopsy with a multidisciplinary cooperative team approach for the management of koreans with cutaneous malignant melanoma.

Authors:  Seok-Jong Lee; Hyun Jung Lim; Ho Youn Kim; Chang Hyun Song; Byung Soo Kim; Weon Ju Lee; Do Won Kim; Jin Hyang Jung; Ho Yong Park; Sang Gul Kim; Ghil Suk Yoon; Jae Tae Lee
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

5.  Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.

Authors:  A Doubrovsky; J H W De Wilt; R A Scolyer; W H McCarthy; J F Thompson
Journal:  Ann Surg Oncol       Date:  2004-08-16       Impact factor: 5.344

6.  Basosquamous carcinoma.

Authors:  Paul H Bowman; John L Ratz; Theresa G Knoepp; Cheryl J Barnes; Eric M Finley
Journal:  Dermatol Surg       Date:  2003-08       Impact factor: 3.398

7.  Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature.

Authors:  H von Domarus; P J Stevens
Journal:  J Am Acad Dermatol       Date:  1984-06       Impact factor: 11.527

8.  Basosquamous carcinoma: analysis of prognostic factors influencing recurrence.

Authors:  R C Martin; M J Edwards; T G Cawte; C L Sewell; K M McMasters
Journal:  Cancer       Date:  2000-03-15       Impact factor: 6.860

  8 in total
  2 in total

1.  Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Plamen Kolev Penev; Julian Ananiev; Andreas Nowak; Yousef Bayyoud; Stanislav Philipov; José-Carlos Cardoso; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-10-02

2.  Basosquamous Carcinoma: A Commentary.

Authors:  Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.